Compass Therapeutics Inc. (CMPX)
NASDAQ · Healthcare
Compass Therapeutics Inc. Shareholder Equity 2023–2025
Compass Therapeutics Inc. annual/quarterly shareholder equity history from 2023 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Compass Therapeutics Inc. shareholder equity for the quarter ending December 31, 2025 were 196.8M, a 57.14% increase year-over-year.
- Compass Therapeutics Inc. shareholder equity for 2025 were 196.8M, a 57.14% increase from 2024.
- Compass Therapeutics Inc. shareholder equity for 2024 were 125.2M, a 15.69% decrease from 2023.
- Compass Therapeutics Inc. shareholder equity for 2023 were 148.5M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Compass Therapeutics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $197 |
| 2024 | $125 |
| 2023 | $149 |
| Compass Therapeutics Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $197 |
| 2024-12-31 | $125 |
| 2023-12-31 | $149 |
Compass Therapeutics Inc. Shareholder Equity — FAQ
Compass Therapeutics Inc. (CMPX) shareholder equity over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CMPX's shareholder equity history?
The chart and table above show Compass Therapeutics Inc.'s shareholder equity by year and by quarter, including the growth rate.